Cargando…
Gene editing and cardiac disease modelling for the interpretation of genetic variants of uncertain significance in congenital heart disease
BACKGROUND: Genomic sequencing in congenital heart disease (CHD) patients often discovers novel genetic variants, which are classified as variants of uncertain significance (VUS). Functional analysis of each VUS is required in specialised laboratories, to determine whether the VUS is disease causati...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10696868/ https://www.ncbi.nlm.nih.gov/pubmed/38049901 http://dx.doi.org/10.1186/s13287-023-03592-1 |
_version_ | 1785154663391166464 |
---|---|
author | Fear, Vanessa S. Forbes, Catherine A. Shaw, Nicole C. Farley, Kathryn O. Mantegna, Jessica L. Htun, Jasmin P. Syn, Genevieve Viola, Helena Cserne Szappanos, Henrietta Hool, Livia Ward, Michelle Baynam, Gareth Lassmann, Timo |
author_facet | Fear, Vanessa S. Forbes, Catherine A. Shaw, Nicole C. Farley, Kathryn O. Mantegna, Jessica L. Htun, Jasmin P. Syn, Genevieve Viola, Helena Cserne Szappanos, Henrietta Hool, Livia Ward, Michelle Baynam, Gareth Lassmann, Timo |
author_sort | Fear, Vanessa S. |
collection | PubMed |
description | BACKGROUND: Genomic sequencing in congenital heart disease (CHD) patients often discovers novel genetic variants, which are classified as variants of uncertain significance (VUS). Functional analysis of each VUS is required in specialised laboratories, to determine whether the VUS is disease causative or not, leading to lengthy diagnostic delays. We investigated stem cell cardiac disease modelling and transcriptomics for the purpose of genetic variant classification using a GATA4 (p.Arg283Cys) VUS in a patient with CHD. METHODS: We performed high efficiency CRISPR gene editing with homology directed repair in induced pluripotent stem cells (iPSCs), followed by rapid clonal selection with amplicon sequencing. Genetic variant and healthy matched control cells were compared using cardiomyocyte disease modelling and transcriptomics. RESULTS: Genetic variant and healthy cardiomyocytes similarly expressed Troponin T (cTNNT), and GATA4. Transcriptomics analysis of cardiomyocyte differentiation identified changes consistent with the patient’s clinical human phenotype ontology terms. Further, transcriptomics revealed changes in calcium signalling, and cardiomyocyte adrenergic signalling in the variant cells. Functional testing demonstrated, altered action potentials in GATA4 genetic variant cardiomyocytes were consistent with patient cardiac abnormalities. CONCLUSIONS: This work provides in vivo functional studies supportive of a damaging effect on the gene or gene product. Furthermore, we demonstrate the utility of iPSCs, CRISPR gene editing and cardiac disease modelling for genetic variant interpretation. The method can readily be applied to other genetic variants in GATA4 or other genes in cardiac disease, providing a centralised assessment pathway for patient genetic variant interpretation. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13287-023-03592-1. |
format | Online Article Text |
id | pubmed-10696868 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-106968682023-12-06 Gene editing and cardiac disease modelling for the interpretation of genetic variants of uncertain significance in congenital heart disease Fear, Vanessa S. Forbes, Catherine A. Shaw, Nicole C. Farley, Kathryn O. Mantegna, Jessica L. Htun, Jasmin P. Syn, Genevieve Viola, Helena Cserne Szappanos, Henrietta Hool, Livia Ward, Michelle Baynam, Gareth Lassmann, Timo Stem Cell Res Ther Research BACKGROUND: Genomic sequencing in congenital heart disease (CHD) patients often discovers novel genetic variants, which are classified as variants of uncertain significance (VUS). Functional analysis of each VUS is required in specialised laboratories, to determine whether the VUS is disease causative or not, leading to lengthy diagnostic delays. We investigated stem cell cardiac disease modelling and transcriptomics for the purpose of genetic variant classification using a GATA4 (p.Arg283Cys) VUS in a patient with CHD. METHODS: We performed high efficiency CRISPR gene editing with homology directed repair in induced pluripotent stem cells (iPSCs), followed by rapid clonal selection with amplicon sequencing. Genetic variant and healthy matched control cells were compared using cardiomyocyte disease modelling and transcriptomics. RESULTS: Genetic variant and healthy cardiomyocytes similarly expressed Troponin T (cTNNT), and GATA4. Transcriptomics analysis of cardiomyocyte differentiation identified changes consistent with the patient’s clinical human phenotype ontology terms. Further, transcriptomics revealed changes in calcium signalling, and cardiomyocyte adrenergic signalling in the variant cells. Functional testing demonstrated, altered action potentials in GATA4 genetic variant cardiomyocytes were consistent with patient cardiac abnormalities. CONCLUSIONS: This work provides in vivo functional studies supportive of a damaging effect on the gene or gene product. Furthermore, we demonstrate the utility of iPSCs, CRISPR gene editing and cardiac disease modelling for genetic variant interpretation. The method can readily be applied to other genetic variants in GATA4 or other genes in cardiac disease, providing a centralised assessment pathway for patient genetic variant interpretation. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13287-023-03592-1. BioMed Central 2023-12-05 /pmc/articles/PMC10696868/ /pubmed/38049901 http://dx.doi.org/10.1186/s13287-023-03592-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Fear, Vanessa S. Forbes, Catherine A. Shaw, Nicole C. Farley, Kathryn O. Mantegna, Jessica L. Htun, Jasmin P. Syn, Genevieve Viola, Helena Cserne Szappanos, Henrietta Hool, Livia Ward, Michelle Baynam, Gareth Lassmann, Timo Gene editing and cardiac disease modelling for the interpretation of genetic variants of uncertain significance in congenital heart disease |
title | Gene editing and cardiac disease modelling for the interpretation of genetic variants of uncertain significance in congenital heart disease |
title_full | Gene editing and cardiac disease modelling for the interpretation of genetic variants of uncertain significance in congenital heart disease |
title_fullStr | Gene editing and cardiac disease modelling for the interpretation of genetic variants of uncertain significance in congenital heart disease |
title_full_unstemmed | Gene editing and cardiac disease modelling for the interpretation of genetic variants of uncertain significance in congenital heart disease |
title_short | Gene editing and cardiac disease modelling for the interpretation of genetic variants of uncertain significance in congenital heart disease |
title_sort | gene editing and cardiac disease modelling for the interpretation of genetic variants of uncertain significance in congenital heart disease |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10696868/ https://www.ncbi.nlm.nih.gov/pubmed/38049901 http://dx.doi.org/10.1186/s13287-023-03592-1 |
work_keys_str_mv | AT fearvanessas geneeditingandcardiacdiseasemodellingfortheinterpretationofgeneticvariantsofuncertainsignificanceincongenitalheartdisease AT forbescatherinea geneeditingandcardiacdiseasemodellingfortheinterpretationofgeneticvariantsofuncertainsignificanceincongenitalheartdisease AT shawnicolec geneeditingandcardiacdiseasemodellingfortheinterpretationofgeneticvariantsofuncertainsignificanceincongenitalheartdisease AT farleykathryno geneeditingandcardiacdiseasemodellingfortheinterpretationofgeneticvariantsofuncertainsignificanceincongenitalheartdisease AT mantegnajessical geneeditingandcardiacdiseasemodellingfortheinterpretationofgeneticvariantsofuncertainsignificanceincongenitalheartdisease AT htunjasminp geneeditingandcardiacdiseasemodellingfortheinterpretationofgeneticvariantsofuncertainsignificanceincongenitalheartdisease AT syngenevieve geneeditingandcardiacdiseasemodellingfortheinterpretationofgeneticvariantsofuncertainsignificanceincongenitalheartdisease AT violahelena geneeditingandcardiacdiseasemodellingfortheinterpretationofgeneticvariantsofuncertainsignificanceincongenitalheartdisease AT cserneszappanoshenrietta geneeditingandcardiacdiseasemodellingfortheinterpretationofgeneticvariantsofuncertainsignificanceincongenitalheartdisease AT hoollivia geneeditingandcardiacdiseasemodellingfortheinterpretationofgeneticvariantsofuncertainsignificanceincongenitalheartdisease AT wardmichelle geneeditingandcardiacdiseasemodellingfortheinterpretationofgeneticvariantsofuncertainsignificanceincongenitalheartdisease AT baynamgareth geneeditingandcardiacdiseasemodellingfortheinterpretationofgeneticvariantsofuncertainsignificanceincongenitalheartdisease AT lassmanntimo geneeditingandcardiacdiseasemodellingfortheinterpretationofgeneticvariantsofuncertainsignificanceincongenitalheartdisease |